Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression
- PMID: 7641689
- PMCID: PMC394445
- DOI: 10.1002/j.1460-2075.1995.tb00040.x
Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression
Abstract
The growth transforming potential of Epstein-Barr virus (EBV) for Burkitt's lymphoma and nasopharyngeal carcinoma is now extended to other neoplasia, such as Hodgkin's disease, peripheral T-cell tumor and gastric cancer. We have generated an EBV recombinant with a selectable marker at the viral thymidine kinase locus. Recombinant EBV was successfully infected into a human T-cell line, MT-2. Following incubation in the selective medium, drug resistant MT-2 cell clones were isolated and proved to be infected with recombinant EBV. EBV-infected MT-2 cell clones expressed EBNA 1 and LMP 1 and very little of EBNA 2, showing the BamHI F promoter-driven latency II form of infection, which is seen in non-B-cell tumors. This is the first report of in vitro generation of latency II type EBV infection. The present system of persistent EBV infection in T cells should be a good model for investigating the pathogenic role of EBV in non-B-cell tumors.
Similar articles
-
Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells.J Exp Med. 1993 Feb 1;177(2):339-49. doi: 10.1084/jem.177.2.339. J Exp Med. 1993. PMID: 8381153 Free PMC article.
-
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.Br J Cancer. 1996 Aug;74(4):625-31. doi: 10.1038/bjc.1996.412. Br J Cancer. 1996. PMID: 8761381 Free PMC article.
-
The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.J Virol. 1992 Dec;66(12):7461-8. doi: 10.1128/JVI.66.12.7461-7468.1992. J Virol. 1992. PMID: 1331531 Free PMC article.
-
Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.Immunol Lett. 2006 Apr 15;104(1-2):83-8. doi: 10.1016/j.imlet.2005.11.003. Epub 2005 Dec 1. Immunol Lett. 2006. PMID: 16386314 Review.
-
EBV-NK cells interactions and lymphoproliferative disorders.Leuk Lymphoma. 1998 May;29(5-6):491-8. doi: 10.3109/10428199809050908. Leuk Lymphoma. 1998. PMID: 9643562 Review.
Cited by
-
Comprehensive Profiling of EBV Gene Expression and Promoter Methylation Reveals Latency II Viral Infection and Sporadic Abortive Lytic Activation in Peripheral T-Cell Lymphomas.Viruses. 2023 Feb 2;15(2):423. doi: 10.3390/v15020423. Viruses. 2023. PMID: 36851637 Free PMC article.
-
Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.J Virol. 2007 Sep;81(18):10092-100. doi: 10.1128/JVI.00358-07. Epub 2007 Jul 11. J Virol. 2007. PMID: 17626071 Free PMC article.
-
The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells.PLoS Pathog. 2015 Dec 22;11(12):e1005344. doi: 10.1371/journal.ppat.1005344. eCollection 2015 Dec. PLoS Pathog. 2015. PMID: 26694854 Free PMC article.
-
Epstein-Barr Virus (EBV)-associated gastric carcinoma.Viruses. 2012 Dec;4(12):3420-39. doi: 10.3390/v4123420. Viruses. 2012. PMID: 23342366 Free PMC article. Review.
-
Epstein-Barr virus and gastric carcinoma.Mol Pathol. 2000 Oct;53(5):255-61. doi: 10.1136/mp.53.5.255. Mol Pathol. 2000. PMID: 11091849 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
